Genopathy
Gene-Disorder Association · Article
Gene
MLLT3
MLLT3 Super Elongation Complex Subunit
Manually curatedApproved treatment annotated
Association Review

In brief

The association between MLLT3 (MLLT3 Super Elongation Complex Subunit) and Ovarian Cancer is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 8
Compounds 1
Trials 97of 3,298 via MLLT3 compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
MLLT3

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Ovarian Cancer

The disorder

19 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

3 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

3,298 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Provenance

References & sources

7 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access